Sarah Ketterer's PFE Position Overview
Sarah Ketterer (via Causeway Capital Management LLC) currently holds 2.07 M shares of Pfizer Inc. (PFE) worth $52.8 M, representing 0.70% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 6 quarters.
Based on 13F filings, Sarah Ketterer has maintained this position in PFE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2024, adding 207,651 shares. Largest reduction occurred in Q4 2024, reducing 378,520 shares.
Analysis based on 13F filings available since 2013 Q2
Sarah Ketterer's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Sarah Ketterer
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2024 | +2 M | New Buy | 2 M | $27.98 |
| Q3 2024 | +207,651 | Add 10.36% | 2.21 M | $28.94 |
| Q4 2024 | -378,520 | Reduce 17.12% | 1.83 M | $26.53 |
| Q1 2025 | +191,465 | Add 10.45% | 2.02 M | $25.34 |
| Q2 2025 | -60,943 | Reduce 3.01% | 1.96 M | $24.24 |
| Q3 2025 | +108,735 | Add 5.54% | 2.07 M | $25.48 |
Sarah Ketterer's Pfizer Investment FAQs
Sarah Ketterer first purchased Pfizer Inc. (PFE) in Q2 2024, acquiring 2,003,659 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Sarah Ketterer has held Pfizer Inc. (PFE) for 6 quarters since Q2 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Sarah Ketterer's largest addition to Pfizer Inc. (PFE) was in Q2 2024, adding 2,003,659 shares worth $56.06 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Sarah Ketterer's firm, Causeway Capital Management LLC, owns 2,072,047 shares of Pfizer Inc. (PFE), valued at approximately $52.8 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Pfizer Inc. (PFE) represents approximately 0.70% of Sarah Ketterer's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Sarah Ketterer's peak holding in Pfizer Inc. (PFE) was 2,211,310 shares, as reported at the end of Q3 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.